Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Fallik

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Research|August 28, 2001
The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cellsS Jacob, M Aguado, D Fallik, et al.
Gastroenterologie Clinique Et Biologique|November 21, 2000
[Response of metastatic colorectal cancers to treatment with CPT11 (irinotecan): implications of the mismatched base repair system]D Fallik, J C Sabourin, F Borrini, et al.
Presse Medicale (Paris, France : 1983)|March 17, 1999
[Iatrogenic dysphagia with severe consequences: simple preventive measures]D Karsenti, D Fallik, J Desrame, et al.
La Revue De Medecine Interne|February 24, 2001
[Small intestine bacterial overgrowth: six case reports and literature review]D Karsenti, D Bechade, D Fallik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II studyJ Taïeb, T Lecomte, T Aparicio, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinomaP Mathurin, B Raynard, S Dharancy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancerD Fallik, M Ychou, J Jacob, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Research|August 28, 2001
The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cellsS Jacob, M Aguado, D Fallik, et al.
Gastroenterologie Clinique Et Biologique|November 21, 2000
[Response of metastatic colorectal cancers to treatment with CPT11 (irinotecan): implications of the mismatched base repair system]D Fallik, J C Sabourin, F Borrini, et al.
Presse Medicale (Paris, France : 1983)|March 17, 1999
[Iatrogenic dysphagia with severe consequences: simple preventive measures]D Karsenti, D Fallik, J Desrame, et al.
La Revue De Medecine Interne|February 24, 2001
[Small intestine bacterial overgrowth: six case reports and literature review]D Karsenti, D Bechade, D Fallik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II studyJ Taïeb, T Lecomte, T Aparicio, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinomaP Mathurin, B Raynard, S Dharancy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancerD Fallik, M Ychou, J Jacob, et al.
Pageof 1